Results 231 to 240 of about 1,821,409 (281)

Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies. [PDF]

J Transl Med
Salvati A, Melone V, Giordano A, Lamberti J, Palumbo D, Palo L, Rea D, Memoli D, Simonis V, Alexandrova E, Silvestro F, Rizzo F, Weisz A, Tarallo R, Nassa G.   +14 more
europepmc   +1 more source

Exploring market dynamics of biological including biosimilar treatments for retinal diseases in Europe: An interrupted time‐series analysis

Acta Ophthalmologica, EarlyView.
Abstract Purpose To assess the impact of biosimilar ranibizumab and on‐patent faricimab market entry on pricing and utilization trends and describe national variation in off‐label bevacizumab use in Europe. Methods Interrupted time series analysis of quarterly sales data (Q1 2018–Q2 2024) in 11 European countries evaluated ranibizumab utilization and ...
Elif Car, Isabelle Huys, Steven Simoens, Arnold G. Vulto   +3 more
wiley   +1 more source

[Drug repositioning prediction based on dynamic feature learning on heterogeneous graphs]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Zhu H, Guo Y, Xin X, Li C, Zhou D.
europepmc   +1 more source

The benefits of multidisciplinary collaboration in the successful management of two complex feline cases

Australian Veterinary Journal, EarlyView.
Despite a frequent misconception that behavioural concerns are diagnoses of exclusion, medical conditions and behavioural disorders are frequently inter‐related. In human medicine, the ‘multidisciplinary team’ approach (MDTA) is considered the most efficacious way of managing patients with complex and chronic health conditions.
BE Bollaert, JM Ley, HE Zulch
wiley   +1 more source

A systematic computational analysis of pharmacological options in neuroinflammatory-induced autism spectrum disorder in children: A potential for drug repositioning. [PDF]

J Biol Methods
Ismail M, Aananou S, Foguem C, Guinhouya KM, Dossou GT, Boudis F, Tchedre K, Vilhelm C, Guinhouya BC, Zitoun D.   +9 more
europepmc   +1 more source

Biology-Informed Matrix Factorization: An AI-Driven Framework for Enhanced Drug Repositioning. [PDF]

Biology (Basel)
Wang Y, Wang Y, Hu Y, Wang J.
europepmc   +1 more source

Patient-derived organoid xenografts model esophageal cancer cachexia and enable assessment of anti-inflammatory drug repositioning. [PDF]

iScience
Lung BC, Leung AK, Wong CW, Wong IY, Lung CCH, Lo AW, Ko JM, Dai W, Kwong DL, Law S, Lung ML, Yu VZ.   +11 more
europepmc   +1 more source

Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches. [PDF]

Proteomics
Perco P, Ley M, Kęska-Izworska K, Wojenska D, Bono E, Walter SM, Fillinger L, Kratochwill K.   +7 more
europepmc   +1 more source

Translational Informatics Driven Drug Repositioning for Neurodegenerative Disease. [PDF]

Curr Neuropharmacol
Zheng X, Chen J, Zhang Y, Hu S, Bi C, Singla RK, Kamal MA, Horimoto K, Shen B.   +8 more
europepmc   +1 more source

Recent advances in drug repositioning and rediscovery for different therapeutic activities utilizing updated technological approaches. [PDF]

Mol Divers
Nossier ES, Anwar MM, El-Zahabi MA.
europepmc   +1 more source